Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Development and validation of the job crafting scale
We developed and validated a scale to measure job crafting behavior in three separate studies conducted in The Netherlands (totalN = 1181). Job crafting is defined as the self-initiated changes that… Expand
C-Type Lectin-Like Molecule-1
- A. Bakker, S. van den Oudenrijn, +15 authors A. Kruisbeek
- Biology, Medicine
- Cancer Research
- 15 November 2004
Acute myeloid leukemia (AML) has a poor prognosis due to treatment-resistant relapses. A humanized anti-CD33 antibody (Mylotarg) showed a limited response rate in relapsed AML. To discover novel AML… Expand
Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants
- A. Bakker, W. Marissen, +10 authors J. Goudsmit
- Biology, Medicine
- Journal of Virology
- 1 July 2005
ABSTRACT The need to replace rabies immune globulin (RIG) as an essential component of rabies postexposure prophylaxis is widely acknowledged. We set out to discover a unique combination of human… Expand
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
- J. T. ter Meulen, A. Bakker, +10 authors A. Osterhaus
- Medicine
- The Lancet
- 25 June 2004
Summary
SARS coronavirus continues to cause sporadic cases of severe acute respiratory syndrome (SARS) in China. No active or passive immunoprophylaxis for disease induced by SARS coronavirus is… Expand
Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome Coronavirus
- E. N. van den Brink, J. T. ter Meulen, +13 authors J. Goudsmit
- Biology, Medicine
- Journal of Virology
- 1 February 2005
ABSTRACT Human monoclonal antibodies (MAbs) were selected from semisynthetic antibody phage display libraries by using whole irradiated severe acute respiratory syndrome (SARS) coronavirus (CoV)… Expand
Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.
- J. Goudsmit, W. Marissen, +7 authors C. Rupprecht
- Biology, Medicine
- The Journal of infectious diseases
- 15 March 2006
The World Health Organization estimates human mortality from endemic canine rabies to be 55,000 deaths/year. Limited supply hampers the accessibility of appropriate lifesaving treatment, particularly… Expand
A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis.
- J. de Kruif, A. Bakker, +4 authors J. Goudsmit
- Medicine
- Annual review of medicine
- 11 January 2007
The currently recommended treatment for individuals exposed to rabies virus is the combined administration of rabies vaccine and rabies immune globulin (RIG). This review sets out the criteria used… Expand
Novel Rabies Virus-Neutralizing Epitope Recognized by Human Monoclonal Antibody: Fine Mapping and Escape Mutant Analysis
- W. Marissen, R. Kramer, +15 authors A. Bakker
- Biology, Medicine
- Journal of Virology
- 15 April 2005
ABSTRACT Anti-rabies virus immunoglobulin combined with rabies vaccine protects humans from lethal rabies infections. For cost and safety reasons, replacement of the human or equine polyclonal… Expand
Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro.
- A. Bakker, G. Marland, +4 authors C. Figdor
- Biology, Medicine
- Cancer research
- 15 November 1995
MHC class I-restricted CTLs specific for antigens expressed by malignant cells are an important component of immune responses against human cancer. Recently, in melanoma a number of melanocyte… Expand
Validation of the Rapid Fluorescent Focus Inhibition Test for Rabies Virus-Neutralizing Antibodies in Clinical Samples
- S. Kostense, S. Moore, +6 authors J. Goudsmit
- Biology, Medicine
- Antimicrobial Agents and Chemotherapy
- 30 April 2012
ABSTRACT Monoclonal antibodies are successful biologics in treating a variety of diseases, including the prevention or treatment of viral infections. CL184 is a 1:1 combination of two human… Expand